Canadian Institutes of Health Research (CIHR), Canada
Canadian Institutes of Health Research
The CIHR Dementia Research Strategy (the Strategy) supports research on the latest preventive, diagnostic and treatment approaches to Alzheimer's disease and related dementia. It consists of an international and a national component. Together, these components allow the Government of Canada to support world-class research on dementia that will contribute to the global pursuit of finding a cure or disease-modifying treatment for dementia by 2025. The Strategy enables Canadian researchers to lead and participate in a new wave of national and international initiatives.
Components of the CIHR Dementia Research Strategy
The CIHR Dementia Research Strategy is composed of two complementary components:
Canadian Consortium on Neurodegeneration in Aging (CCNA)
The national component of the Strategy, the Canadian Consortium on Neurodegeneration in Aging (CCNA), aims to accelerate innovative and collaborative Canadian research in neurodegenerative diseases in aging that have an impact on cognition.
The international component of the Strategy, formerly known as the International Collaborative Research Strategy for Alzheimer's Disease, facilitates the participation of Canadian researchers in key international partnerships.
It is expected that this Strategy will increase the impact of the research and will enable Canadian researchers to lead and participate in the opportunities offered by a new wave of national and international initiatives. In addition, the CCNA is well positioned to help Canada respond to the World Health Organization Report "Dementia – A Public Health Priority" calling on countries to collaborate to find solutions to the cause and treatment of dementia.
Participating center of excellence:
Canadian Consortium on Neurodegeneration in Aging (CCNA) - http://ccna-ccnv.ca/en/